News that not one but two COVID-19 vaccines have tested 95 per cent effective casts a welcome burst of light into Canada’s gloomy COVID-19 narrative, amid signs the pandemic is ripping into the nation’s social fabric.
Moderna announced that its vaccine candidate proved 94.5 per cent effective in trials. Meanwhile, Pfizer and its partner BioNTech followed up their earlier announcement by confirming final results are five per cent higher than the 90 per cent originally announced.
Further review and regulatory approvals still await, including here in Canada. But the companies say first doses could ship as early as the end of November.
But hold the rooftop cheering.